Publicaciones en colaboración con investigadores/as de Trinity College Dublin (23)

2023

  1. Can amphotericin B and itraconazole be co-delivered orally? Tailoring oral fixed-dose combination coated granules for systemic mycoses

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 183, pp. 74-91

  2. Co-Delivery of a High Dose of Amphotericin B and Itraconazole by Means of a Dry Powder Inhaler Formulation for the Treatment of Severe Fungal Pulmonary Infections

    Pharmaceutics, Vol. 15, Núm. 11

  3. Continuous Manufacturing of Cocrystals Using 3D-Printed Microfluidic Chips Coupled with Spray Coating

    Pharmaceuticals, Vol. 16, Núm. 8

  4. Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers

    International journal of pharmaceutics, Vol. 635, pp. 122788

2022

  1. Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions

    AAPS PharmSciTech, Vol. 23, Núm. 7

2021

  1. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms

    International Journal of Pharmaceutics, Vol. 597

2020

  1. Personalised 3d printed medicines: Optimising material properties for successful passive diffusion loading of filaments for fused deposition modelling of solid dosage forms

    Pharmaceutics, Vol. 12, Núm. 4

2019

  1. Designing fast-dissolving orodispersible films of amphotericin b for oropharyngeal candidiasis

    Pharmaceutics, Vol. 11, Núm. 8

  2. Predicting the critical quality attributes of ibuprofen tablets via modelling of process parameters for roller compaction and tabletting

    International Journal of Pharmaceutics, Vol. 565, pp. 209-218

2018

  1. Drug delivery nanosystems for the localized treatment of glioblastoma multiforme

    Materials, Vol. 11, Núm. 5

  2. Engineering of pharmaceutical cocrystals in an excipient matrix: Spray drying versus hot melt extrusion

    International Journal of Pharmaceutics, Vol. 551, Núm. 1-2, pp. 241-256

  3. New aerosol formulation to control ciprofloxacin pulmonary concentration

    Journal of Controlled Release, Vol. 271, pp. 118-126

  4. Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 124, pp. 13-27

  5. Production of cocrystals in an excipient matrix by spray drying

    International Journal of Pharmaceutics, Vol. 536, Núm. 1, pp. 467-477

2017

  1. A Comparative Study on the Performance of Inert and Functionalized Spheres Coated with Solid Dispersions Made of Two Structurally Related Antifungal Drugs

    Molecular Pharmaceutics, Vol. 14, Núm. 11, pp. 3718-3728

  2. Engineering oral and parenteral amorphous amphotericin B formulations against experimental Trypanosoma cruzi infections

    Molecular Pharmaceutics, Vol. 14, Núm. 4, pp. 1095-1106

2016

  1. Cocrystal habit engineering to improve drug dissolution and alter derived powder properties

    Journal of Pharmacy and Pharmacology, Vol. 68, Núm. 5, pp. 665-677

  2. Impact of Substrate Properties on the Formation of Spherulitic Films: A Case Study of Salbutamol Sulfate

    Crystal Growth and Design, Vol. 16, Núm. 7, pp. 3853-3858

  3. Modelling and shadowgraph imaging of cocrystal dissolution and assessment of in vitro antimicrobial activity for sulfadimidine/4-aminosalicylic acid cocrystals

    European Journal of Pharmaceutical Sciences, Vol. 89, pp. 125-136

2015

  1. Emerging nanonisation technologies: Tailoring crystalline versus amorphous nanomaterials

    Current Topics in Medicinal Chemistry, Vol. 15, Núm. 22, pp. 2327-2340